News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Miguel_Ángel_Ávila_Antonio_Oliviero_Neurofix
#BIOSPAIN2023Interview | "Prevention, management, and treatment of neurological diseases are far from satisfactory"
BioSpain
Antonio Oliviero, Chief Medical Officer of Neurofix, Bronze Sponsor of BIOSPAIN 2023, discusses the…
Enrique Berlanas Merck
Merck's Advance Biotech Grant | "We aim to support biotechnological startups that are developing new advanced therapies"
BioSpain
Enrique Berlanas, Managing Director of Merck Life Science in Spain, shares all the details of this…
Jose_Miguel_Vela_Welab
#BIOSPAIN2023Interview | "There is a significant gap between the generation of knowledge and its transformation into a new asset that can benefit patients"
BioSpain
José Miguel Vela, CSO of Welab, Bronze Sponsor of BIOSPAIN 2023, discusses the current gap in the…
oryzon-noticia-socio-asebio-biotech
Oryzon announces completed patient recruitment in the PORTICO Phase IIb trial of vafidemstat in Borderline Personality Disorder
Corporate
Multiple primary endpoints include reduction in agitation and aggression and overall disease…
Oryzon-Asebio-Biotecnologia
ORYZON reports financial results and corporate updates for half-year ending June 30, 2023
Corporate
Susana de Antonio Head of Listing Spain de Euronext
#BIOSPAIN2023Interview | "We aim to facilitate the growth of European companies and help them become global leaders"
BioSpain
Susana de Antonio Horcajo, Head of Listing Spain at Euronext and Bronze Sponsor of BIOSPAIN 2023,…
Dámaso_Molero_CEO_3P_Biopharmaceuticals
#BIOSPAIN2023Interview | "We are witnessing scientific and technological advances that are revolutionizing the sector"
BioSpain
Dámaso Molero, CEO of 3P Biopharmaceuticals, Silver Sponsor of BIOSPAIN 2023, analyzes the snapshot…
Orikine
Orikine Bio closes €5.5m Series Seed Financing with Sabadell Asabys and AdBio
Financing · Corporate
New synthetic biology spin-off from the Centre for Genomic Regulation (CRG) in Barcelona developing…
Ignacio_Odriozola_LIM_Global
#BIOSPAIN2023 Interview | "Research continues to be underfunded and lacks sufficient resources"
BioSpain · Talento
In recent years, Spain has achieved significant progress that has improved its ability to attract…